NFKB1 and cancer: NF-κB activity dramatically decreased by STAT3 RNAi in many STAT3 constitutive activated cancer cells [23], suggesting that STAT3 inhibitors may also play potential roles in blocking NF-κB activity and enhancing growth inhibition in these cancer cells.